Celgene's Multiple Myeloma Triplet Succeeds in Key Phase III Trial Post author:Sam Post published:February 5, 2018 Post category:BioPharma The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace You Might Also Like New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017 AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal December 28, 2017 Federal Court Overturns Gilead Sciences and Merck Patent Dispute February 19, 2018
New Wirelessly Powered Scalable Retinal Prosthesis, University of California, San Diego (UCSD) Reveals March 16, 2017
